On the other hand, it was found in the study of Serretta et al., (2008) that the rate of prostate cancer frequency in cases with PSA levels increasing or remaining unchanged following antibiotherapy was statistically higher as compared to those with decreasing PSA levels. The gene discussed is KLK3; the disease is prostate carcinoma.